Posted by admin on Aug 18th, 2022
Gorman-Rupp (NYSE:GRC – Get Rating) was upgraded by StockNews.com from a “sell” rating to a “hold” rating in a note issued to investors on Thursday.
Separately, TheStreet lowered Gorman-Rupp from a “b-” rating to a “c+” rating in a research report on Wednesday, June 8th.
Shares of GRC opened at $27.32 on Thursday. Gorman-Rupp has a 12-month low of $26.83 and a 12-month high of $47.12. The business has a 50-day simple moving average of $28.33 and a two-hundred day simple moving average of $32.44. The company has a quick ratio of 1.33, a current ratio of 2.42 and a debt-to-equity ratio of 1.27. The stock has a market cap of $712.92 million, a PE ratio of 32.52 and a beta of 0.64.
A number of hedge funds and other institutional investors have recently modified their holdings of the company. Quantbot Technologies LP purchased a new stake in shares of Gorman-Rupp in the 2nd quarter worth approximately $28,000. Bell Investment Advisors Inc bought a new stake in Gorman-Rupp during the fourth quarter valued at about $29,000. Tompkins Financial Corp bought a new stake in Gorman-Rupp during the second quarter valued at about $34,000. Kepos Capital LP bought a new stake in Gorman-Rupp during the fourth quarter valued at about $71,000. Finally, Acadian Asset Management LLC purchased a new position in shares of Gorman-Rupp during the first quarter valued at about $77,000. 55.88% of the stock is currently owned by hedge funds and other institutional investors.
The Gorman-Rupp Company designs, manufactures, and sells pumps and pump systems in the United States and internationally. The company's products include self-priming centrifugal, standard centrifugal, magnetic drive centrifugal, axial and mixed flow, vertical turbine line shaft, submersible, high pressure booster, rotary gear, diaphragm, bellows, and oscillating pumps.
Receive News & Ratings for Gorman-Rupp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gorman-Rupp and related companies with MarketBeat.com's FREE daily email newsletter.
Tesco (OTCMKTS:TSCDD) Stock Price Down 0.2%
CASI Pharmaceuticals (NASDAQ:CASI) Coverage Initiated by Analysts at StockNews.com